# A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study)

> **NCT05686369** · — · COMPLETED · sponsor: **Chugai Pharmaceutical** · enrollment: 12 (actual)

## Conditions studied

- Celiac Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05686369
- **Lead sponsor:** Chugai Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-08
- **Primary completion:** 2023-10-05
- **Final completion:** 2023-10-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05686369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05686369, "A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT05686369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*